
    
      Background Peanut allergy is severe and rarely resolves.

      Objective To test the efficacy and safety of a new oral immunotherapy protocol for peanut
      allergy.

      Method 22 peanut-allergic children will undergo oral challenge. Oral immunotherapy will be
      administered by gradual updosing with 2-weekly increments (8-38w) to 800mg protein (5
      peanuts/day) followed by 30-weeks maintenance. Oral challenge will be repeated after 6 and 30
      weeks maintenance.
    
  